首页> 外国专利> compound of the formula (i), formula (ii) or formula (iii), pharmaceutical composition, method for treating a condition or disorder in which ttx-s channel blockers are involved, compound of either formula or a drug thereof or a pharmaceutically acceptable salt and process for preparing a pharmaceutical composition

compound of the formula (i), formula (ii) or formula (iii), pharmaceutical composition, method for treating a condition or disorder in which ttx-s channel blockers are involved, compound of either formula or a drug thereof or a pharmaceutically acceptable salt and process for preparing a pharmaceutical composition

机译：式（i），式（ii）或式（iii）的化合物，药物组合物，用于治疗涉及ttx-s通道阻滞剂的疾病或病症的方法，式或其化合物或药学上可接受的化合物盐和制备药物组合物的方法

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to pyrrolopyridinone derivatives which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.

机译：本发明涉及吡咯并吡啶酮衍生物，其具有作为TTX-S通道的电压门控钠通道的阻断活性，并且可用于治疗或预防涉及电压门控钠通道的病症和疾病。本发明还涉及包含这些化合物的药物组合物，以及这些化合物和组合物在预防或治疗涉及电压门控钠通道的疾病中的用途。

著录项

公开/公告号BR112014026283A2

专利类型
公开/公告日2017-06-27

原文格式PDF
申请/专利权人 RAQUALIA PHARMA INC.;
展开▼

申请/专利号BR20141126283
发明设计人 KIYOSHI KAWAMURA;MIKIO MORITA;TATSUYA YAMAGISHI;
展开▼

申请日2013-04-25
分类号A61K31/44;A61P25;A61P25/04;A61P25/06;A61P29;A61P43;C07D471/04;
国家 BR
入库时间 2022-08-21 13:40:25

相似文献

专利
外文文献
中文文献